Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

255 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Dreyling M, Ghielmini M, Rule S, Salles G, Ladetto M, Tonino SH, Herfarth K, Seymour JF, Jerkeman M; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Dreyling M, et al. Among authors: herfarth k. Ann Oncol. 2021 Mar;32(3):298-308. doi: 10.1016/j.annonc.2020.11.008. Epub 2020 Nov 26. Ann Oncol. 2021. PMID: 33249059 Free article. No abstract available.
Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial.
König L, Dreyling M, Dürig J, Engelhard M, Hohloch K, Viardot A, Witzens-Harig M, Kieser M, Klapper W, Pott C, Herfarth K. König L, et al. Among authors: herfarth k. Trials. 2019 Aug 30;20(1):544. doi: 10.1186/s13063-019-3614-y. Trials. 2019. PMID: 31470902 Free PMC article.
Localized- and advanced-stage follicular lymphomas differ in their gene expression profiles.
Staiger AM, Hoster E, Jurinovic V, Winter S, Leich E, Kalla C, Möller P, Bernd HW, Feller AC, Koch K, Klapper W, Stein H, Hansmann ML, Hartmann S, Dreyling M, Weigert O, Hiddemann W, Herfarth K, Rosenwald A, Engelhard M, Ott G, Horn H. Staiger AM, et al. Among authors: herfarth k. Blood. 2020 Jan 16;135(3):181-190. doi: 10.1182/blood.2019000560. Blood. 2020. PMID: 31697802 Free article. Clinical Trial.
[Use of multimodal treatment for early-stage follicular lymphoma].
Witzens-Harig M, Herfarth K. Witzens-Harig M, et al. Among authors: herfarth k. Dtsch Med Wochenschr. 2009 Sep;134(39):1953-5. doi: 10.1055/s-0029-1237539. Epub 2009 Sep 16. Dtsch Med Wochenschr. 2009. PMID: 19760559 German. No abstract available.
Clinical outcome of patients with follicular lymphoma and bulky disease after rituximab-CHOP immunochemotherapy with and without consolidating radiotherapy.
McClanahan F, Hielscher T, Rieger M, Hensel M, Neben K, Hillengass J, Herfarth K, Ho AD, Witzens-Harig M. McClanahan F, et al. Among authors: herfarth k. Eur J Haematol. 2010 Jul;85(1):11-9. doi: 10.1111/j.1600-0609.2010.01445.x. Epub 2010 Mar 16. Eur J Haematol. 2010. PMID: 20331739 Clinical Trial.
Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma: Results of the MIR Study.
Herfarth K, Borchmann P, Schnaidt S, Hohloch K, Budach V, Engelhard M, Viardot A, Engenhart-Cabillic R, Keller U, Reinartz G, Eich HT, Witzens-Harig M, Hess CF, Dörken B, Dürig J, Wiegel T, Hiddemann W, Hoster E, Pott C, Dreyling M. Herfarth K, et al. Hemasphere. 2018 Nov 30;2(6):e160. doi: 10.1097/HS9.0000000000000160. eCollection 2018 Dec. Hemasphere. 2018. PMID: 31723798 Free PMC article.
255 results